Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.03 USD | +1.60% | +4.83% | +38.72% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.72% | 2.87B | |
+15.46% | 121B | |
+13.56% | 107B | |
-4.72% | 24.82B | |
+1.54% | 22.48B | |
-9.86% | 18.32B | |
-42.28% | 16.33B | |
-16.08% | 15.31B | |
+3.93% | 14.08B | |
+26.22% | 11.74B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Insider Sell: Ptc Therapeutics